top of page
  • Writer's pictureDTxCC

Pharma Digital Health Commercial Assessment

Updated: Feb 7, 2021

Lupin Pharmaceuticals, Inc. manufactures, markets and/or distributes more than 160 drugs in the United States.

Lupin is interested in entering the digital health / digital therapeutic sector

DTxCC conducts a commercial assessment to develop a clear understanding of the US marketplace and opportunities for a digital health/therapeutic offering

Go-to-market strategies

  • ROI/NPV Investment Evaluation

  • Incremental sales forecast

  • Supporting evidence/promotions needed for commercial success

  • Organizational capabilities needed for commercial success

132 views0 comments

Recent Posts

See All


bottom of page